- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 2 - Lifestyle Modification Programs-Do They Work?
Despite the potential benefits of weight loss intervention programs, Peter Salgo, MD, and panelists Maria Lopes, MD, MS; Kari Uusinarkaus, MD, FAAFP, FNLA; Jeffrey D. Dunn, PharmD, MBA; and Yehuda Handelsman, MD, FACP, FACE, FNLA, explain that many barriers affect the outcomes of these programs.
Dr Salgo emphasizes that weight reduction is a crucial part of diabetes care; lifestyle modifications such as losing weight, making dietary changes, and increasing physical activity level are recommended for patients with diabetes. However, Dr Salgo explains that adherence to lifestyle modifications is challenging for many patients.
Dr Lopes agrees that lifestyle modification and wellness programs work; however, they are successful in only a minority of patients. Dr Uusinarkaus adds that healthcare professionals need to select the right patients for the right programs; ultimately, patients need to be inspired to be responsible for their own health.
Drs Handelsman and Dunn discuss the high costs associated with weight loss intervention programs, and consider what parties should be responsible for program expenses.
Together, the panelists conclude that a stronger governmental and societal approach can help combat the obesity epidemic.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More
